M.D. Anderson Cancer Center Newswire (Page 7)

M.D. Anderson Cancer Center Newswire (Page 7)

Comprehensive Real-Time News Feed for M.D. Anderson Cancer Center. (Page 7)

Results 121 - 140 of 6,140 in M.D. Anderson Cancer Center

  1. Disparities seen in gastric cancer patients' receipt of pre-op chemoRead the original story w/Photo

    Feb 13, 2018 | PhysOrg Weblog

    Racial and ethnic disparities in the use of preoperative chemotherapy exist among patients with gastric cancer in the United States, according to a study published online Feb. 2 in Cancer . Naruhiko Ikoma, M.D., from the University of Texas MD Anderson Cancer Center in Houston, and colleagues used the National Cancer Data Base to identify 16,945 patients with clinical T2-4bN0-1M0 gastric adenocarcinoma, who underwent gastrectomy during 2006 to 2014.

    Comment?

  2. Obesity Associated with Longer Survival for Men with Metastatic MelanomaRead the original story w/Photo

    Feb 13, 2018 | Health News Digest

    Obese patients with metastatic melanoma who are treated with targeted or immune therapies live significantly longer than those with a normal body mass index , investigators report in a study published in Lancet Oncology of 1,918 patients in six independent clinical cohorts. This effect, referred to as the "Obesity Paradox", principally manifested itself in men, said Jennifer McQuade, M.D., lead author and instructor of Melanoma Medical Oncology at The University of Texas MD Anderson Cancer Center.

    Comment?

  3. Smart Bomb Virus Shows Promise as Brain Tumor ImmunotherapyRead the original story

    Feb 13, 2018 | Health News Digest

    A common cold virus engineered to attack the most common and deadly of brain tumors allowed 20 percent of patients with recurrent glioblastoma to live for three years or longer, researchers from The University of Texas MD Anderson Cancer Center report on a phase I clinical trial in the Journal of Clinical Oncology . The altered adenovirus, called Delta-24-RGD or DNX-2401, was injected one time directly into the tumors of 25 patients whose glioblastoma had recurred after surgery and other treatments, a patient group that typically has a median survival of six months.

    Comment?

  4. Way to Attack Deadly, Untreatable Nerve TumorsRead the original story w/Photo

    Feb 13, 2018 | Health News Digest

    Genomic profiling of mostly untreatable and deadly nerve sheath tumors led scientists to test a possible therapeutic strategy that inhibited tumor growth in lab tests on human tumor cells and mouse models, according to research in the journal Cancer Cell. When the international team of researchers analyzed complete screens of genes and genetic material in malignant peripheral nerve sheath tumors , it revealed previously unknown genetic information about the disease.

    Comment?

  5. Study suggests way to attack deadly, untreatable nerve tumorsRead the original story w/Photo

    Feb 13, 2018 | Science, Industry and Business

    Genomic profiling of mostly untreatable and deadly nerve sheath tumors led scientists to test a possible therapeutic strategy that inhibited tumor growth in lab tests on human tumor cells and mouse models, according to research in the journal Cancer Cell . This microscopic image uses immunostaining to highlight the presence of TAZ/YAP in human malignant peripheral nerve sheath tumors that grew from Schwann cells.

    Comment?

  6. Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'Read the original story

    Feb 12, 2018 | Nature Reviews Clinical Oncology

    Primary analysis of Juliet: a global, pivotal, phase 2 trial of CTL019 in adult patients with relapsed or refractory diffuse large B-cell lymphoma High durable CR rates in relapsed/refractory aggressive B-NHL treated with the CD19-directed CAR T cell product JCAR017 : defined composition allows for dose-finding and definition of pivotal cohort Analysis of a global registration trial of the efficacy and safety of CTL019 in pediatric and young adults with relapsed/refractory acute lymphoblastic leukemia Severe neurotoxicity in the phase 2 trial of JCAR015 in adult B-ALL : analyses of patient, protocol and product attributes. in 32nd Annual SITC Meeting .

    Comment?

  7. Lauren M. WarrenRead the original story w/Photo

    Feb 12, 2018 | Times-Union

    Lauren M. Warren, 26, New Paris, died at 1:13 p.m. Thursday, Feb. 8, 2018, at MD Anderson Cancer Center, Houston, Texas, after a four-month battle with mesothelioma. Lauren lived her lifetime in this area.

    Comment?

  8. Dr Sumit Subudhi Discusses Immune Checkpoint Inhibitors in Prostate CancerRead the original story w/Photo

    Feb 11, 2018 | The American Journal of Managed Care

    In prostate cancer, we're using combinations by looking to see how 1 drug may trigger an immune infiltrate or proteins that allow the tumor to resist the monotherapy, said Sumit Subudhi, MD, PhD, genitourinary medical oncology, MD Anderson Cancer Center. In prostate cancer, combination therapies are being used to see how 1 drug may trigger an immune infiltrate or proteins that allow the tumor to resist the monotherapy, said Sumit Subudhi, MD, PhD, genitourinary medical oncology, Cancer Medicine, MD Anderson Cancer Center.

    Comment?

  9. Texas guard Jones engaging public as he battles cancerRead the original story w/Photo

    Feb 9, 2018 | Texarkana Gazette

    The announcement that Texas guard Andrew Jones was diagnosed with leukemia prompted concern and well wishes from across college basketball. Jones is now starting to offer glimpses of how he is coping with his treatment, and sending "thank you" messages for the emotional and financial support that has poured in.

    Comment?

  10. Preclinical evaluation and reverse phase protein Array-based...Read the original story w/Photo

    Feb 8, 2018 | BioMed Central

    ... KLE and SKUT2 were obtained from the Department of Systems Biology, the University of Texas M.D. Anderson Cancer Center (Houston, USA), EN, MFE296 and MFE280 cell lines were purchased from the German Collection of Microorganisms and Cell Cultures ...

    Comment?

  11. Using AI in a Compliance Function - Part IRead the original story w/Photo

    Feb 9, 2018 | JD Supra

    I have long been an advocate of technology in compliance to facilitate more effective, cost efficient operationalization of a corporate compliance function or as I call it ComTech. I find the intersection of compliance, technology and artificial intelligence , to be particularly compelling as I believe it will make compliance much more robust in the three prongs of prevent, detect and remediate.

    Comment?

  12. Texas guard Jones engaging public as he battles cancerRead the original story w/Photo

    Feb 9, 2018 | NewsOK.com

    The announcement that Texas guard Andrew Jones was diagnosed with leukemia prompted concern and well wishes from across college basketball. Jones is now starting to offer glimpses of how he is coping with his treatment, and sending "thank you" messages for the emotional and financial support that has poured in.

    Comment?

  13. House welcomes back Del. Terry Austin after cancer surgeryRead the original story w/Photo

    Feb 8, 2018 | Powhatan Today

    You have reached the limit of 5 free articles per 30 days. To continue, log in now or sign up for a digital Richmond Times-Dispatch subscription for only $8.99 per month.

    Comment?

  14. IRIS Appoints Chris Belmont as Interim Chief Executive OfficerRead the original story w/Photo

    Feb 7, 2018 | Vision Monday

    PENSACOLA, Fla.- Intelligent Retinal Imaging Systems , an industry leader in early detection systems for diabetic eye disease, has appointed Chris Belmont as interim chief executive officer. He succeeds Jason Crawford, who stepped down in January.

    Comment?

  15. Fast-spinning spheres show nanoscale systems secretsRead the original story

    Feb 7, 2018 | PressReleasePoint

    Spin a merry-go-round fast enough and the riders fly off in all directions. But the spinning particles in a Rice University lab do just the opposite.

    Comment?

  16. Teen cancer patient marks emotional end to treatment with bell ringingRead the original story w/Photo

    Feb 7, 2018 | The Arizona Republic

    Phoenix teen Jorge Rivera reached a milestone of ending his radiation treatment for Ewing's sarcoma, a rare type of bone cancer on Tuesday. Jorge Rivera, 18, of Phoenix, receives his final radiation treatment for Ewing's sarcoma, a rare bone cancer, at Banner Desert Medical Center in Mesa.

    Comment?

  17. Why More Scientists Are Running For Office in 2018Read the original story w/Photo

    Feb 7, 2018 | Time

    Getting scientists to become more politically involved has been an ongoing movement this year, with groups like the American Association for the Advancement of Science and American Chemical Society encouraging scientists to voice their opinions and even join protests, like the March for Science in April 2017 . Now, hundreds of scientists and STEM professionals are running for public office in 2018, for everything from Senate seats to a spot on the local school board.

    Comment?

  18. Fast-spinning spheres show nanoscale systems' secretsRead the original story w/Photo

    Feb 6, 2018 | EurekAlert!

    Spin a merry-go-round fast enough and the riders fly off in all directions. But the spinning particles in a Rice University lab do just the opposite.

    Comment?

  19. Moleculin Announces Activity with Pancreatic Cancer DrugRead the original story w/Photo

    Feb 7, 2018 | Market Wire

    ... the development of anti-cancer drug candidates, some of which are based on discoveries made at M.D. Anderson Cancer Center. Our clinical stage drugs are Annamycin, an anthracycline being studied for the treatment of relapsed or refractory acute ...

    Comment?

  20. 6 Warning Signs of Stomach CancerRead the original story w/Photo

    Feb 6, 2018 | Runner's World

    Stomach cancer has a reputation for being one of the most painful forms of cancer. But for many sufferers, pain is not among the disease's early warning signs.

    Comment?